Filing Flows › Comparisons › HRTX vs VTVT
Heron Therapeutics vs vTv Therapeutics: HRTX and VTVT compared
Heron Therapeutics is the larger company: $37.7M of revenue in its latest quarter (Q2 2026) against $36.8M for vTv Therapeutics (Q1 2026). vTv Therapeutics is more profitable, with an operating margin of 63.1% against -5.4%.
Where the money goes: HRTX and VTVT
Heron Therapeutics (HRTX) · Q2 2026
Heron Therapeutics, Q2 2026: revenue $37.7M (+1% year over year), operating margin -5.4%, net loss $5.5M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
vTv Therapeutics (VTVT) · Q1 2026
vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.
| Heron Therapeutics (HRTX) | vTv Therapeutics (VTVT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 2026 |
| Revenue | $37.7M | $36.8M |
| Revenue growth, Y/Y | +1% | — |
| Operating margin | -5.4% | 63.1% |
| Net earnings | −$5.5M | $24.1M |
| Net margin | -14.6% | 65.5% |
| Operating cash flow | −$2.2M | $9.2M |
Where the revenue comes from
Heron Therapeutics
- CINVANTI: $21.8M (58%)
- ZYNRELEF: $11.1M (29%)
- Aponvie: $4.3M (11%)
- SUSTOL: $540K (1%)
Questions
Which is bigger, Heron Therapeutics or vTv Therapeutics?
Heron Therapeutics is the larger company: $37.7M of revenue in its latest quarter (Q2 2026) against $36.8M for vTv Therapeutics (Q1 2026).
Is Heron Therapeutics or vTv Therapeutics growing faster?
vTv Therapeutics is more profitable, with an operating margin of 63.1% against -5.4%.
More: Heron Therapeutics earnings · how Heron Therapeutics makes money · vTv Therapeutics earnings · how vTv Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed May 13, 2026). Fiscal quarters can end on different dates. Not investment advice.